Peter A. te Boekhorst

696 total citations
8 papers, 331 citations indexed

About

Peter A. te Boekhorst is a scholar working on Genetics, Hematology and Molecular Biology. According to data from OpenAlex, Peter A. te Boekhorst has authored 8 papers receiving a total of 331 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Genetics, 4 papers in Hematology and 1 paper in Molecular Biology. Recurrent topics in Peter A. te Boekhorst's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers), Chronic Myeloid Leukemia Treatments (2 papers) and Cancer Cells and Metastasis (1 paper). Peter A. te Boekhorst is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers), Chronic Myeloid Leukemia Treatments (2 papers) and Cancer Cells and Metastasis (1 paper). Peter A. te Boekhorst collaborates with scholars based in Netherlands, Italy and France. Peter A. te Boekhorst's co-authors include Claire Harrison, Alessandro M. Vannucchi, Andrew C. Perkins, Judit Demeter, Miklós Egyed, Jean‐Jacques Kiladjian, Anita Szőke, Jack W. Singer, Ritam Prasad and Aleksandr Suvorov and has published in prestigious journals such as Blood, Cancer Research and American Journal of Neuroradiology.

In The Last Decade

Peter A. te Boekhorst

8 papers receiving 329 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter A. te Boekhorst Netherlands	6	238	225	126	94	36	8	331
Rodolphe Besancenot France	6	252 1.1×	227 1.0×	166 1.3×	88 0.9×	35 1.0×	9	348
Jiřı́ Schwarz Czechia	11	249 1.0×	245 1.1×	220 1.7×	64 0.7×	31 0.9×	36	403
Hajime Akada United States	7	331 1.4×	266 1.2×	244 1.9×	101 1.1×	53 1.5×	12	437
Jonas S. Jutzi United States	10	282 1.2×	250 1.1×	238 1.9×	109 1.2×	36 1.0×	21	422
F.-X. Mahon France	11	268 1.1×	323 1.4×	68 0.5×	162 1.7×	51 1.4×	20	414
Klaudia Bagienski Austria	4	319 1.3×	268 1.2×	200 1.6×	115 1.2×	15 0.4×	7	365
Pencho Georgiev Bulgaria	11	127 0.5×	230 1.0×	97 0.8×	49 0.5×	33 0.9×	30	333
Tina L. Hamilton United Kingdom	8	168 0.7×	206 0.9×	232 1.8×	39 0.4×	23 0.6×	8	344
Alfonso Quintás-Cardama United States	9	265 1.1×	305 1.4×	87 0.7×	185 2.0×	58 1.6×	17	416
Ann‐Mari Forsblom Sweden	6	170 0.7×	312 1.4×	183 1.5×	14 0.1×	51 1.4×	12	395

Countries citing papers authored by Peter A. te Boekhorst

Since Specialization

Citations

This map shows the geographic impact of Peter A. te Boekhorst's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter A. te Boekhorst with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter A. te Boekhorst more than expected).

Fields of papers citing papers by Peter A. te Boekhorst

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter A. te Boekhorst. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter A. te Boekhorst. The network helps show where Peter A. te Boekhorst may publish in the future.

Co-authorship network of co-authors of Peter A. te Boekhorst

This figure shows the co-authorship network connecting the top 25 collaborators of Peter A. te Boekhorst. A scholar is included among the top collaborators of Peter A. te Boekhorst based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter A. te Boekhorst. Peter A. te Boekhorst is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Blijlevens, Nicole M. A., Saskia K. Klein, W. M. Smit, et al.. (2022). P709: CLINICAL OUTCOME OF ASCIMINIB TREATMENT IN A REAL-WORLD MULTI-RESISTANT CML PATIENT POPULATION.. HemaSphere. 6. 604–605. 6 indexed citations

Dessel, Lisanne F. van, Jaco Kraan, Rui P. Neves, et al.. (2020). Abstract 3919: Liquid biopsy derived organoids as a potential platform for personalized cancer therapy in metastatic prostate cancer. Cancer Research. 80(16_Supplement). 3919–3919. 1 indexed citations

Guglielmelli, Paola, Jean‐Jacques Kiladjian, Alessandro M. Vannucchi, et al.. (2020). The Final Analysis of Expand: A Phase 1b, Open-Label, Dose-Finding Study of Ruxolitinib (RUX) in Patients (pts) with Myelofibrosis (MF) and Low Platelet (PLT) Count (50 × 109/L to < 100 × 109/L) at Baseline. Blood. 136(Supplement 1). 4–5. 5 indexed citations

Mesa, Ruben A., Alessandro M. Vannucchi, Adam J. Mead, et al.. (2017). Pacritinib versus best available therapy for the treatment of myelofibrosis irrespective of baseline cytopenias (PERSIST-1): an international, randomised, phase 3 trial. The Lancet Haematology. 4(5). e225–e236. 221 indexed citations

Vannucchi, Alessandro M., Heinz Gisslinger, Claire Harrison, et al.. (2015). EXPAND: A Phase 1b, Open-Label, Dose-Finding Study of Ruxolitinib in Patients with Myelofibrosis (MF) and Low Platelet Counts (50 × 109/L to 99 × 109/L) at Baseline. Blood. 126(23). 2817–2817. 7 indexed citations

Vannucchi, Alessandro M., Ruben A. Mesa, Francisco Cervantes, et al.. (2015). Analysis of Outcomes By Patient Subgroups in Patients with Myelofibrosis Treated with Pacritinib Vs Best Available Therapy (BAT) in the Phase III Persist-1 Trial. Blood. 126(23). 58–58. 7 indexed citations

Schonewille, Henk, et al.. (2015). Incidence of alloantibody formation after ABO‐D or extended matched red blood cell transfusions: a randomized trial (MATCH study). Transfusion. 56(2). 311–320. 52 indexed citations

Rocca, Maria A., Paola Valsasina, Maria Pia Sormani, et al.. (2007). A Three-Year Study of Brain Atrophy after Autologous Hematopoietic Stem Cell Transplantation in Rapidly Evolving Secondary Progressive Multiple Sclerosis. American Journal of Neuroradiology. 28(9). 1659–1661. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact